| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MACROGENICS INC | Director | Stock Option (right to buy) | 33.6K | $123K | $3.66 | May 21, 2024 | Direct |
| MACROGENICS INC | Director | Restricted Stock Unit | 6.5K | $118K | $18.22 | May 21, 2024 | Direct |
| MACROGENICS INC | Director | Common Stock | 4.5K | $82K | $18.22 | May 20, 2024 | Direct |
| Vallon Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 15K | Feb 23, 2022 | Direct | ||
| Apexigen, Inc. | Director | Stock Option (right to buy) | 0 | Aug 23, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MGNX | MACROGENICS INC | May 21, 2024 | 3 | $62.5K | 4 | May 23, 2024 | Director |
| MGNX | MACROGENICS INC | May 20, 2024 | 2 | $0 | 4 | May 22, 2024 | Director |
| APGN | Apexigen, Inc. | Aug 23, 2023 | 1 | $0 | 4 | Aug 25, 2023 | Director |
| MGNX | MACROGENICS INC | May 31, 2023 | 3 | $0 | 4 | Jun 2, 2023 | Director |
| MGNX | MACROGENICS INC | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| MGNX | MACROGENICS INC | Jan 3, 2023 | 0 | $0 | 3 | Jan 5, 2023 | Director |
| APGN | Apexigen, Inc. | Sep 29, 2022 | 1 | $0 | 4 | Oct 3, 2022 | Director |
| APGN | Apexigen, Inc. | Jul 29, 2022 | 0 | $0 | 3 | Aug 8, 2022 | Director |
| GRI | Vallon Pharmaceuticals, Inc. | Feb 23, 2022 | 1 | $115K | 4 | Mar 9, 2022 | Director |
| GRI | Vallon Pharmaceuticals, Inc. | Feb 23, 2022 | 0 | $0 | 3 | Mar 9, 2022 | Director |